{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:19:42Z","timestamp":1759940382841},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.9037-17","type":"journal-article","created":{"date-parts":[[2017,9,24]],"date-time":"2017-09-24T18:09:01Z","timestamp":1506276541000},"page":"3089-3092","source":"Crossref","is-referenced-by-count":6,"title":["\"Brief\" Aripiprazole-induced Neuroleptic Malignant Syndrome with Symptoms that Only Lasted a Few Hours"],"prefix":"10.2169","volume":"56","author":[{"given":"Naoto","family":"Mizumura","sequence":"first","affiliation":[{"name":"Department of Surgery, Bellland General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Uematsu","sequence":"additional","affiliation":[{"name":"Postgraduate Education Center, Bellland General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Surgery, Bellland General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Okumura","sequence":"additional","affiliation":[{"name":"Department of Surgery, Bellland General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Maehira","sequence":"additional","affiliation":[{"name":"Department of Surgery, Bellland General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Bellland General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayasu","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Department of Surgery, Bellland General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gurrera RJ, Caroff SN, Cohen A, et al. An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry 72: 1222-1228, 2011.","DOI":"10.4088\/JCP.10m06438"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Picard LS, Lindsay S, Strawn JR, Kaneria RM, Patel NC, Keck PE Jr. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations. Pharmacotherapy 28: 530-535, 2008.","DOI":"10.1592\/phco.28.4.530"},{"key":"3","unstructured":"3. Belvederi Murri M, Guaglianone A, Bugliani M, et al. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis. Drugs R D 15: 45-62, 2015."},{"key":"4","unstructured":"4. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text revision. American Psychiatric Association, Ed. Medication-induced movement disorders: neuroleptic malignant syndrome. American Psychiatric Association, Washington, D.C., 2000: 795-798."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 142: 1137-1145, 1985.","DOI":"10.1176\/ajp.142.10.1137"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Rosebush PI, Mazurek MF. Serum iron and neuroleptic malignant syndrome. Lancet 338: 149-151, 1991.","DOI":"10.1016\/0140-6736(91)90138-F"},{"key":"7","unstructured":"7. Burtis CA, Ashwood ER, Bruns DE. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 5th ed. Elsevier, Philadelphia, PA, 2012: 985-1030."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Mohammed R, McColl KE, Veitch D, Young R, Cumming RL, Parikh RK. Changes in iron metabolism following surgery. Br J Surg 70: 161-162, 1983.","DOI":"10.1002\/bjs.1800700308"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Dale JC, Burritt MF, Zinsmeister AR. Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels. Am J Clin Pathol 117: 802-808, 2002.","DOI":"10.1309\/2YT4-CMP3-KYW7-9RK1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tsuchiya N, Morimura E, Hanafusa T, Shinomura T. Postoperative neuroleptic malignant syndrome that occurred repeatedly in a patient with cerebral palsy. Paediatr Anaesth 17: 281-284, 2007.","DOI":"10.1111\/j.1460-9592.2006.02079.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Patel P, Bristow G. Postoperative neuroleptic malignant syndrome. A case report. Can J Anaesth 34: 515-518, 1987.","DOI":"10.1007\/BF03014361"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Amore M, Zazzeri N. Neuroleptic malignant syndrome after neuroleptic discontinuation. Prog Neuropsychopharmacol Biol Psychiatry 19: 1323-1334, 1995.","DOI":"10.1016\/0278-5846(95)00269-3"},{"key":"13","unstructured":"13. Zhao Z, Zhang H, Wang S, Chen X. Sudden discontinuation and reinstitution of olanzapine-associated atypical neuroleptic malignant syndrome in a patient undergoing lung surgery. Int J Clin Exp Med 8: 11639-11641, 2015."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lee JW. Serum iron in catatonia and neuroleptic malignant syndrome. Biol Psychiatry 44: 499-507, 1998.","DOI":"10.1016\/S0006-3223(98)00109-7"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Patil BS, Subramanyam AA, Singh SL, Kamath RM. Low serum iron as a possible risk factor for neuroleptic malignant syndrome. Int J Appl Basic Med Res 4: 117-118, 2014.","DOI":"10.4103\/2229-516X.136800"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Keck PE, Pope HG, Cohen BM, Mcelroy SL, Nierenberg AA. Risk factors for neuroleptic malignant syndrome. A case-control study. Arch Gen Psychiatry 46: 914-918, 1989.","DOI":"10.1001\/archpsyc.1989.01810100056011"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Trollor JN, Chen X, Chitty K, Sachdev PS. Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics. Br J Psychiatry 201: 52-56, 2012.","DOI":"10.1192\/bjp.bp.111.105189"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Greenblatt HK, Greenblatt DJ. Use of Antipsychotics for the treatment of behavioral symptoms of dementia. J Clin Pharmacol 56: 1048-1057, 2016.","DOI":"10.1002\/jcph.731"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/22\/56_9037-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T18:32:56Z","timestamp":1570127576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/22\/56_9037-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":18,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9037-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}